Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

Bill Steinman
Contributing Editor

Gary Giampetruzzi: Is Small Pharma next for DOJ enforcement?

For decades, U.S. prosecutors have touted their big victories over big pharma for violations of U.S. laws prohibiting bribery in the U.S. (the federal Anti-Kickback Statute) and abroad (the FCPA). 

After paying tens of billions of dollars in fines and penalties, it appears that big pharma may have received the message and responded by taking compliance seriously and investing in the resources needed to identify and address risk areas.… Continue Reading

Practice alert: China adopts new rules on healthcare donations

Last week, China’s chief healthcare regulator, the National Health and Family Planning Commission (NHFPC), published a significant revision to its earlier rules on donations to healthcare entities. This category of entities includes the nation’s network of state-run hospitals and clinics where about 90 percent of citizens get their healthcare. 

The revised rule, titled Administrative Measures on Accepting Donations for Public Welfare by Healthcare Entities (for Trial Implementation) (the “New Donation Measures,” see original Chinese here and Covington’s English translation here), replaced the Administrative Measures on the Acceptance of Donations and Sponsorships (“2007 Measures”), which was promulgated in 2007.… Continue Reading